These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 26197850)
1. A different interpretation of the efficacy of lung cancer screening in the PLCO trial. Sagawa M; Nakayama T; Sobue T; Eur J Epidemiol; 2016 Feb; 31(2):211-2. PubMed ID: 26197850 [No Abstract] [Full Text] [Related]
2. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Miller AB; Yurgalevitch S; Weissfeld JL; Control Clin Trials; 2000 Dec; 21(6 Suppl):400S-406S. PubMed ID: 11189691 [TBL] [Abstract][Full Text] [Related]
3. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Andriole GL Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777 [TBL] [Abstract][Full Text] [Related]
4. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. O'Brien B; Nichaman L; Browne JE; Levin DL; Prorok PC; Gohagan JK; Control Clin Trials; 2000 Dec; 21(6 Suppl):310S-328S. PubMed ID: 11189685 [TBL] [Abstract][Full Text] [Related]
6. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS; Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689 [TBL] [Abstract][Full Text] [Related]
7. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Weissfeld JL; Fagerstrom RM; O'Brien B; Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690 [TBL] [Abstract][Full Text] [Related]
8. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Simpson NK; Johnson CC; Ogden SL; Gamito E; Trocky N; McGuire C; Martin J; Barrow S; Lamerato L; Flickinger LM; Broski KG; Engelhard D; Hilke C; Bonk J; Gahagan B; Gren LH; Childs J; Lappe K; Fouad M; Thompson J; Sullivan D; Control Clin Trials; 2000 Dec; 21(6 Suppl):356S-378S. PubMed ID: 11189688 [TBL] [Abstract][Full Text] [Related]
9. ACS releases updated guidelines on cancer screening. Lambert M Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051 [No Abstract] [Full Text] [Related]
10. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Gohagan JK; Prorok PC; Hayes RB; Kramer BS; Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683 [TBL] [Abstract][Full Text] [Related]
11. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Hasson MA; Fagerstrom RM; Kahane DC; Walsh JH; Myers MH; Caughman C; Wenzel B; Haralson JC; Flickinger LM; Turner LM; Control Clin Trials; 2000 Dec; 21(6 Suppl):329S-348S. PubMed ID: 11189686 [TBL] [Abstract][Full Text] [Related]
12. Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial. Grubb RL; Pinsky P; Prorok PC; Andriole GL Eur Urol; 2015 Oct; 68(4):545-6. PubMed ID: 25959167 [TBL] [Abstract][Full Text] [Related]
16. Building Successful Relationships in the PLCO Cancer Screening Trial. Marcus PM; Broski KG; Buys SS; Childs J; Church TR; Gohagan JK; Gren LH; Higgins D; Jaggi R; Jenkins V; Johnson CC; Lappe K; O'Brien B; Ogden SL; Prorok PC; Reding D; Shambaugh V; Yokochi LA; Yurgalevitch S Rev Recent Clin Trials; 2015; 10(3):181-6. PubMed ID: 26238208 [TBL] [Abstract][Full Text] [Related]
17. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Hayes RB; Reding D; Kopp W; Subar AF; Bhat N; Rothman N; Caporaso N; Ziegler RG; Johnson CC; Weissfeld JL; Hoover RN; Hartge P; Palace C; Gohagan JK; Control Clin Trials; 2000 Dec; 21(6 Suppl):349S-355S. PubMed ID: 11189687 [TBL] [Abstract][Full Text] [Related]
18. Data Processing and Analytic Support in the PLCO Cancer Screening Trial. Mabie J; Riley T; Marcus PM; Black A; Rozjabek H; Yu K; Young M; Austin J; Rathmell J; Williams C; Prorok PC Rev Recent Clin Trials; 2015; 10(3):233-7. PubMed ID: 26238116 [TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK; J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007 [TBL] [Abstract][Full Text] [Related]
20. ERSPC, PLCO studies and critique of cochrane review 2013. Schröder FH Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]